HEALTH OF WOMAN. 2020.9-10(155-156): 71-75; doi 10.15574/HW.2020.155-156.71
Malanchuk L. M., Pitcyk I. B., Malanchuk A. S., Martyniuk V. M., Malanchuk S. L.
Ternopil National Medical University named after I.Ya. Gorbachev Ministry of Health of Ukraine

The problem of cervical diseases has become especially relevant due to the increasing frequency of this pathology and impaired generative function of the female body .Complex economic and unfavorable environmental conditions of Ukraine, which cause a state of chronic distress, inadequate reproductive behavior lead to the development of cervical tumors. An important role of immune protection of the genital tract belongs to the microbiocenosis of the vagina. After all, analyzing the anatomical structure of the reproductive system, physical, chemical and immunological variations of changes in the endothelium of the genital tract depending on the age of the woman, as well as the phase of the menstrual cycle, violation of vaginal normocenosis is a trigger of cervical pathology.
According to the world literature, there is a close relationship between sexually transmitted infections and the development of cervical neoplasia. As early as the 1970s, Harald Zur Hausen took an important step in studying the pathogenesis of cervical cancer and identified the leading role of oncogenic types of human papillomavirus in this process .
Prevention of the development of malignant neoplasms of the cervix, which occupy the fifth place in the structure of oncogynecological pathology in our country and the second place among oncological morbidity, is an urgent problem and meets the principles of modern medicine.
Keywords: pathology of the cervix, human papilloma virus, vaginal microbiocenosis.

REFERENCES

1. Bayramova GR, Baranov II, Ezhova LS, Trofimov DYu, Priputnevich TV, Amirhanyan AS, Starinskaya AM. 2019. Ploskokletochnyie intraepitelialnyie porazheniya sheyki matki: vozmozhnosti ranney diagnostiki i taktiki vedeniya patsientok. Doktor.Ru. 11(166):61–67.

2. Fokom Domgue J, Messick C, Milbourne A, Guo M, Salcedo MP, Dahlstrom KR, Chiao EY, Deshmukh AA, Sturgis EM, Schmeler KM. 2019, May. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 153(2):266-270. https://doi.org/10.1016/j.ygyno.2019.02.024; PMid:30827725 PMCid:PMC7104617

3. Berlev IV, Bahidze EV, Arhangelskaya PA. 2015. Znachenie otsenki narusheniy biotsenoza vlagalischa v aspekte diagnostiki i lecheniya preinvazivnyih neoplaziy sheyki matki. Zh. akush. i zhen. bolezn. 5.

4. Vdovychenko YuP, Hopchuk OM. 2016. Bakterialnyi vahinoz – monoterapiia kombinovanymy preparatamy. Zdorove zhenshchyny 1:132–136. https://doi.org/10.15574/HW.2016.107.132

5. Diudiun AD, Kruzhnova OV, Hladyshev VV. 2013. Kompleksne likuvannia khvorykh na bakterialnyi vahinoz z urakhuvanniam mikrobiotychnykh ta imunnykh porushen. Dermatovenerolohyia. Kosmetolohyia. Seksopatolohyia. 1–4:21–29.

6. Zhorzh ON, Mirzabalaeva AK. 2009. Tsitomorfologicheskaya harakteristika epiteliya sheyki matki pri hronicheskom retsidiviruyuschem kandidoze genitaliy i bakterialnom vaginoze. Problemyi meditsinskoy mikologii 2.

7. Menuhova YuN. 2013. Bakterialnyiy vaginoz: etiopatogenez, kliniko-laboratornyie osobennosti. Zh. akush. i zhen. bolezn. 4.

8. Nahorna VF, Moskalenko TIa, Hrytsenko AA, Manasova HS, Shukhtin VV, Shukhtina IM. 2016. Bakterialnyi vahinoz: interpretatsiia danykh klinichnykh ta paraklinichnykh doslidzhen. Vrachebnoe delo 7–8:96–99.

9. Pestrikova TYu, Yurasova EA, Kotelnikova AV. 2018. Bakterialnyiy vaginoz, sochetannyiy s tservitsitom: effektivnost lecheniya. Doktor.Ru. 6(150):30–33.

10. Savrun SS, Zadorozhna TD. 2012. Morfolohichni ta imunohistokhimichni markery ploskoklitynnykh dysplazii shyiky matky. Aktualni pytannia pediatrii, akusherstva ta hinekolohii 2:137–139.

11. Grema BA, Aliyu I, Michael GC, Mafala MB. 2019, Jan-Apr. Diagnosing Premalignant Lesions of Uterine Cervix in A ResourceConstraint Setting: A Narrative Review. West Afr J Med. 36(1):48-53.

12. Selihova MS, Smolyaninov AA. 2019. Novyie vozmozhnosti v lechenii vaginalnyih infektsiy. Akusherstvo i ginekologiya: Novosti. Mneniya. Obuchenie 1 (23).

13. Rachkovskaya VV, Gorbunov AP, Pashov LV, Volkova LV. 2020. Primenenie mass-spektrometrii pri diagnostike patologii sheyki matki (obzor literaturyi). Sibirskoe meditsinskoe obozrenie 3(123):30–37. https://doi.org/10.20333/2500136-2020-3-30-37

14. Chilova RA, Proklova GF, Goncharenko NV. 2020. Problemyi differentsialnoy diagnostiki i lecheniya bakterialnogo vaginoza. RMZh. Mat i ditya 1:77–82, 124–127.

15. Aminodova IP, Posiseeva LV. 2016. Retsidiviruyuschaya displaziya sheyki matki – faktoryi riska i vozmozhnosti ih korrektsii. Perspektivyi etapnoy terapii. Research’n Practical Medicine Journal. Spetsvyipusk.

16. Labzina MV, Labzina LYa, Nechaykin AS i dr. 2020. Analiz rezultatov kolposkopii v diagnostike neoplaziy sheyki matki. Byulleten nauki i praktiki 2:103–105.

17. Gomes de Oliveira G, Eleutério RMN, Silveira Gonçalves AK, Giraldo PC, Eleutério J Jr. 2018. Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing. Acta Cytol. 62(1):28-33. https://doi.org/10.1159/000481654; PMid:29130974

18. Belokrinitskaya TE, Ponomareva YuN, Bunina EN. 2005. Kliniko-epidemiologicheskie aspektyi zabolevaniy sheyki matki, assotsiirovannyih s virusami papillom. Dalnevostochnyiy meditsinskiy zhurnal 1:88–92.

19. Blesmanovich AE, Petrov YuA, Alehina AG. 2019. Faktoryi riska i preventivnaya diagnostika raka sheyki matki. Zdorove i obrazovanie v XXI veke 1:23–29.

20. Venediktova MG, Sarantsev AN, Morozova KV, Orudzhova KF. 2019. Sovremennyiy vzglyad na kompleksnuyu terapiyu displazii sheyki matki v usloviyah infitsirovaniya virusom papillomy cheloveka. RMZh. Mat i ditya 3:46–51.

21. Hnatko OP, Skuriatina NH, Berezhna TA. 2018. Diahnostychne znachennia markeriv proliferatsii u vyznachenni stupenia vazhkosti peredrakovykh staniv shyiky matky. Aktualni pytannia pediatrii, akusherstva ta ginekologii 1:56–61.

22. Dzhalalova PM, Tomilova IK, Aleksahina EL, Lapochkina NP. 2016. Rol lokalnogo oksidativnogo stressa v patogeneze intraepitelialnoy displazii i raka sheyki matki. Research’n Practical Medicine Journal.

23. Kashtalian NM. 2018. Abliatsiine likuvannia endometriozu ta dobroiakisnoi patolohii shyiky matky na tli slabkoi dysplazii. Odeskyi medychnyi zhurnal 2:63–67.

24. Cooper DB, McCathran CE. Cervical Dysplasia. 202tatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan.

25. Kindrativ EO. 2018. Matematychne modeliuvannia prohnozuvannia protsesu prohresuvannia dysplazii shyiky matky, shcho asotsiiovana z papilomavirusnoiu infektsiieiu u zhinok, khvorykh na bezpliddia. Morphologia. 12;4:41–47. https://doi.org/10.26641/1997-9665.2018.4.41-47

26. Shefer VV, Krutova VA, Chuprinenko LM, Sobol TV, Podmogilnyiy NN. 2018. Osobennosti techeniya i taktiki vedeniya patsientok s displasticheskimi sostoyaniyami sheyki matki na fone narusheniya mikrobiotsenoza vlagalischa. Kubanskiy nauchnyiy meditsinskiy vestnik 2:105–109.

27. Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. 2019, Jul. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 221(1):9-18.e8. https://doi.org/10.1016/j.ajog.2018.12.011; PMid:30550767